ACTIVE

CONVERT PHARMACEUTICALS

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
-629,3 k €
+2.6% YoY
Gross margin
-247,9 k €
+51.8% YoY
Equity
-841,8 k €
+27.7% YoY

What does CONVERT PHARMACEUTICALS do?

CONVERT PHARMACEUTICALS is a Public limited company incorporated in 2017. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Liège.

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0671.828.631
Incorporation
24/02/2017
Legal form
Public limited company
Registered office
Esplanade Simone VEIL 1
4000 Liège · WallonieSee on map
Contributed capital
2 472 683,00 €
Latest accounts
31/12/2025
Activities (NACE)
72109Research and experimental development on natural sciences and engineering· main72190Other research and experimental development on natural sciences and engineering
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 9 financial years

202520242023202220212020201920182017
Income statement
Gross margin-247,9 k €-513,9 k €-80,3 k €78,4 k €116,3 k €202,6 k €95,5 k €136,5 k €-26,3 k €
EBITDA-248,1 k €-517,7 k €-146,7 k €5,9 k €44 k €201,8 k €-224,7 k €-168,9 k €-139,5 k €
Operating result-549,1 k €-741,2 k €-455,6 k €-478,4 k €-522,4 k €-324,9 k €-1,5 M €-2,1 M €-1,1 M €
Net result-629,3 k €-645,8 k €-616,3 k €-501,4 k €-277,3 k €-350,1 k €421,5 k €-1 M €-576,1 k €
Balance sheet
Equity-841,8 k €-1,2 M €-1,4 M €-798,2 k €-296,8 k €-19,5 k €330,6 k €-90,9 k €944,1 k €
Total assets941,2 k €1,2 M €357,2 k €1 M €1,6 M €1,8 M €2,6 M €1,8 M €1,3 M €
Cash158,3 k €551,6 k €75,1 k €527,7 k €647,6 k €291 k €46,3 k €218,2 k €118,7 k €
Debts1,8 M €2,1 M €1,8 M €1,8 M €1,9 M €1,8 M €2,3 M €1,9 M €401,5 k €
Other
Workforce––66 197,7 ETP0,3 ETP––5,8 ETP4,6 ETP1,8 ETP
Governance

Board of directors

Seen on filing of 31/12/2020 · 2 active · 14 ended

Active mandates

Paul Tulcinsky

Director · since 06 mars 2020 · until 31 mai 2026

Active
Philippe Lambin

Director · since 24 février 2017 · until 31 mai 2026

Active

Ended mandates

Alain Van Strydonck

Director · since 06 mars 2020 · until 31 mai 2026

Ended
Mariola Soehngen

Managing director · since 11 janvier 2019 · until 06 mars 2020

Ended
Mariola Soehngen

Managing director · since 11 janvier 2019 · until 31 mai 2023

Ended
Paul Tulcinsky

Director · since 02 octobre 2017 · until 11 janvier 2019

Ended
At this address

Other companies at this address

CompanyCBE no.
18.24 Agency● Active
0749.671.032
ACTICARGO● Active
1039.306.302
AD And Partner● Active
1018.445.758
Aïssako● Active
1025.564.865
AML Services● Active
0771.320.640
ANA CREATIVES● Active
1023.972.283
ANOMIS● Active
0745.547.740
ARXEN● Active
1025.285.347
ASTREIYA● Bankrupt
0800.053.624
B&A CONCEPT● Active
0697.853.137
Batisphère Construction● Active
1004.773.609
beCAD● Active
0809.610.203
Bnewable Ground● Active
0799.563.377
CAIR BELGIUM● Active
0870.712.778
Clinova Health● Active
1038.833.178
CONCRIT● Active
0561.905.360
Customs Facility Agency● Active
1030.130.397
CVE INVEST● Active
0724.730.550
DATA INTELLIGENCE COMMUNITY EXPERTS● Active
0737.751.316
DAYIMA● Active
1004.849.229
Annual accounts

Full financial information

202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date17/06/202626/06/202506/06/202408/06/202312/07/202222/06/2021
General meeting01/06/202602/06/202531/05/202431/05/202331/05/202231/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

9 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202501/06/202617/06/2026FrenchPDF
Abridged model31/12/202402/06/202526/06/2025FrenchPDF
Abridged model31/12/202331/05/202406/06/2024FrenchPDF
Abridged model31/12/202231/05/202308/06/2023FrenchPDF
Abridged model31/12/202131/05/202212/07/2022FrenchPDF
Abridged model31/12/202031/05/202122/06/2021FrenchPDF
Abridged model31/12/201902/06/202029/06/2020FrenchPDF
Abridged model31/12/201831/05/201902/07/2019FrenchPDF
Abridged model31/12/201731/05/201809/08/2018FrenchPDF
Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2020 · 2 active · 14 ended

Active mandates

Paul Tulcinsky

Director · since 06 mars 2020 · until 31 mai 2026

Active
Philippe Lambin

Director · since 24 février 2017 · until 31 mai 2026

Active

Ended mandates

Alain Van Strydonck

Director · since 06 mars 2020 · until 31 mai 2026

Ended
Mariola Soehngen

Managing director · since 11 janvier 2019 · until 06 mars 2020

Ended
Mariola Soehngen

Managing director · since 11 janvier 2019 · until 31 mai 2023

Ended
Paul Tulcinsky

Director · since 02 octobre 2017 · until 11 janvier 2019

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates07/09/2026
    Renouvellement du mandat d'un administrateur
    PDF
  • Mandates31/07/2026
    DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE
    PDF
  • Mandates29/08/2025
    SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
    PDF
  • Capital / shares07/07/2025
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS
    PDF
  • Mandates11/03/2020
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates18/04/2019
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates24/10/2017
    DEMISSIONS, NOMINATIONS
    PDF
  • Registered office15/09/2017
    SIEGE SOCIAL
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-629,3 k €↑
  2. 2024
    Annual accounts 2024-645,8 k €↓
  3. 2023
    Annual accounts 2023-616,3 k €↓
  4. 2022
    Annual accounts 2022-501,4 k €↓
  5. 2021
    Annual accounts 2021-277,3 k €↑
  6. 2020
    Annual accounts 2020-350,1 k €↓
  7. 2019
    Annual accounts 2019421,5 k €↑
  8. 2018
    Annual accounts 2018-1 M €↓
  9. 2017
    Annual accounts 2017-576,1 k €
  10. 24/02/2017
    IncorporationPublic limited company